|
US5837258A
(en)
|
1991-08-30 |
1998-11-17 |
University Of South Florida |
Induction of tissue, bone or cartilage formation using connective tissue growth factor
|
|
DE10160151A1
(de)
|
2001-01-09 |
2003-06-26 |
Ribopharma Ag |
Verfahren zur Hemmung der Expression eines vorgegebenen Zielgens
|
|
EP1873259B1
(en)
|
2000-12-01 |
2012-01-25 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
RNA interference mediated by 21 and 22nt RNAs
|
|
US20050282188A1
(en)
|
2001-05-18 |
2005-12-22 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
|
|
US20080188430A1
(en)
|
2001-05-18 |
2008-08-07 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
|
|
WO2003035876A1
(de)
|
2001-10-26 |
2003-05-01 |
Ribopharma Ag |
Verwendung einer doppelsträngigen ribonukleinsäure zur behandlung einer infektion mit einem (+)-strang-rna-virus
|
|
US20040138163A1
(en)
|
2002-05-29 |
2004-07-15 |
Mcswiggen James |
RNA interference mediated inhibition of vascular edothelial growth factor and vascular edothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
|
EP3222724B1
(en)
|
2002-08-05 |
2018-10-31 |
Silence Therapeutics GmbH |
Further novel forms of interfering rna molecules
|
|
WO2006006948A2
(en)
|
2002-11-14 |
2006-01-19 |
Dharmacon, Inc. |
METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
|
|
EP2314691A3
(en)
|
2002-11-14 |
2012-01-18 |
Dharmacon, Inc. |
Fuctional and hyperfunctional siRNA
|
|
ATE479752T1
(de)
|
2003-03-07 |
2010-09-15 |
Alnylam Pharmaceuticals Inc |
Therapeutische zusammensetzungen
|
|
US20040198640A1
(en)
|
2003-04-02 |
2004-10-07 |
Dharmacon, Inc. |
Stabilized polynucleotides for use in RNA interference
|
|
US20050136437A1
(en)
|
2003-08-25 |
2005-06-23 |
Nastech Pharmaceutical Company Inc. |
Nanoparticles for delivery of nucleic acids and stable double-stranded RNA
|
|
US20060134787A1
(en)
|
2004-12-22 |
2006-06-22 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended siRNA
|
|
WO2005062937A2
(en)
|
2003-12-22 |
2005-07-14 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended sirna
|
|
WO2005079533A2
(en)
|
2004-02-17 |
2005-09-01 |
University Of Massachusetts |
Methods and compositions for mediating gene silencing
|
|
EP2365077B1
(en)
|
2004-03-12 |
2013-05-08 |
Alnylam Pharmaceuticals, Inc. |
iRNA agents targeting VEGF
|
|
KR101147147B1
(ko)
|
2004-04-01 |
2012-05-25 |
머크 샤프 앤드 돔 코포레이션 |
Ｒｎａ 간섭의 오프 타겟 효과 감소를 위한 변형된폴리뉴클레오타이드
|
|
EP1793835A4
(en)
|
2004-09-10 |
2010-12-01 |
Somagenics Inc |
SMALL INTERFERING RNA EFFECTIVELY INHIBITING VIRAL GENE EXPRESSION AND METHODS OF USE THEREOF
|
|
TWI386225B
(zh)
*
|
2004-12-23 |
2013-02-21 |
Alcon Inc |
用於治療眼睛病症的結締組織生長因子（ＣＴＧＦ）ＲＮＡ干擾（ＲＮＡｉ）抑制技術
|
|
US20060142228A1
(en)
|
2004-12-23 |
2006-06-29 |
Ambion, Inc. |
Methods and compositions concerning siRNA's as mediators of RNA interference
|
|
NZ563845A
(en)
|
2005-04-08 |
2010-09-30 |
Marina Biotech Inc |
RNAi sequences against the Influenza A segment 1 PB2 gene and uses thereof as anti-viral therapeutic
|
|
EP1891216B1
(en)
|
2005-05-25 |
2012-02-22 |
The University Of York |
Hybrid interfering rna
|
|
MX2007016083A
(es)
|
2005-06-24 |
2008-03-10 |
Intervet Int Bv |
Vacunas quimericas inactivadas y metodos relacionados de uso.
|
|
FR2890859B1
(fr)
|
2005-09-21 |
2012-12-21 |
Oreal |
Oligonucleotide d'arn double brin inhibant l'expression de la tyrosinase
|
|
US7825099B2
(en)
|
2006-01-20 |
2010-11-02 |
Quark Pharmaceuticals, Inc. |
Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
|
|
EP1986609A2
(en)
|
2006-01-26 |
2008-11-05 |
University of Massachusetts |
Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same
|
|
CN103215293B
(zh)
|
2006-01-27 |
2015-10-28 |
比奥根Ma公司 |
Nogo受体拮抗剂
|
|
US20070218495A1
(en)
|
2006-03-16 |
2007-09-20 |
Dharmacon, Inc. |
Methods, libraries and computer program products for gene silencing with reduced off-target effects
|
|
US7700541B2
(en)
|
2006-04-06 |
2010-04-20 |
Nitto Denko Corporation |
Biodegradable cationic polymers
|
|
GB0608838D0
(en)
|
2006-05-04 |
2006-06-14 |
Novartis Ag |
Organic compounds
|
|
US20100105134A1
(en)
|
2007-03-02 |
2010-04-29 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting gene expression and uses thereof
|
|
EP2468864A1
(en)
|
2007-03-02 |
2012-06-27 |
Marina Biotech, Inc. |
Nucleic acid compounds for inhibiting VEGF family gene expression and uses thereof
|
|
WO2008150897A2
(en)
|
2007-05-31 |
2008-12-11 |
University Of Iowa Research Foundation |
Reduction of off-target rna interference toxicity
|
|
US20090004668A1
(en)
|
2007-06-22 |
2009-01-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pre-miRNA loop-modulated target regulation
|
|
WO2009020344A2
(en)
|
2007-08-06 |
2009-02-12 |
Postech Acad Ind Found |
Small interfering rnas (sirnas) controlling multiple target genes and method for preparing the same
|
|
EP3121281B1
(en)
|
2007-08-27 |
2021-03-31 |
1Globe Health Institute LLC |
Compositions of asymmetric interfering rna and uses thereof
|
|
EP2195428B1
(en)
|
2007-09-19 |
2013-12-11 |
Applied Biosystems, LLC |
SiRNA SEQUENCE-INDEPENDENT MODIFICATION FORMATS FOR REDUCING OFF-TARGET PHENOTYPIC EFFECTS IN RNAi, AND STABILIZED FORMS THEREOF
|
|
AU2008306455C1
(en)
|
2007-10-03 |
2014-04-17 |
Quark Pharmaceuticals, Inc. |
Novel siRNA structures
|
|
US8614311B2
(en)
|
2007-12-12 |
2013-12-24 |
Quark Pharmaceuticals, Inc. |
RTP801L siRNA compounds and methods of use thereof
|
|
KR100949791B1
(ko)
|
2007-12-18 |
2010-03-30 |
이동기 |
오프-타겟 효과를 최소화하고 ＲＮＡｉ 기구를 포화시키지않는 신규한 ｓｉＲＮＡ 구조 및 그 용도
|
|
AU2009215795A1
(en)
|
2008-02-21 |
2009-08-27 |
University Of Kentucky Research Foundation |
Ultra-small RNAs as toll-like receptor-3 antagonists
|
|
WO2010011346A1
(en)
|
2008-07-24 |
2010-01-28 |
Rxi Pharmaceuticals Corporation |
Rnai constructs and uses therof
|
|
US8580562B2
(en)
|
2008-09-08 |
2013-11-12 |
Fukuoka University |
Inhibitory RNA for modulating the molecular function of ZFAT gene
|
|
JP2012502991A
(ja)
|
2008-09-22 |
2012-02-02 |
アールエックスアイ ファーマシューティカルズ コーポレーション |
皮膚適用におけるｒｎａ干渉
|
|
US20100227920A1
(en)
|
2008-09-29 |
2010-09-09 |
The Regents Of The University Of California |
Aldehyde dehydrogenase inhibitors as novel depigmenting agents
|
|
WO2010090762A1
(en)
|
2009-02-04 |
2010-08-12 |
Rxi Pharmaceuticals Corporation |
Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
|
|
WO2010094491A1
(en)
|
2009-02-18 |
2010-08-26 |
Silence Therapeutics Ag |
Means for inhibiting the expression of ang2
|
|
JP2012520683A
(ja)
*
|
2009-03-19 |
2012-09-10 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸（ｓｉＮＡ）を用いた結合組織増殖因子（ＣＴＧＦ）遺伝子発現のＲＮＡ干渉媒介性阻害
|
|
KR101207561B1
(ko)
|
2009-12-15 |
2012-12-04 |
주식회사 코리아나화장품 |
티로시나제의 발현을 저해하는 ｓｉＲＮＡ 올리고뉴클레오타이드 및 이를 함유하는 화장료 조성물
|
|
WO2011084193A1
(en)
|
2010-01-07 |
2011-07-14 |
Quark Pharmaceuticals, Inc. |
Oligonucleotide compounds comprising non-nucleotide overhangs
|
|
CN106074591B
(zh)
|
2010-03-24 |
2020-01-14 |
菲奥医药公司 |
眼部症候中的rna干扰
|
|
EP2550002B1
(en)
*
|
2010-03-24 |
2019-05-08 |
Phio Pharmaceuticals Corp. |
Rna interference in dermal and fibrotic indications
|
|
WO2011140659A1
(en)
|
2010-05-12 |
2011-11-17 |
Centre Hospitalier De L'universite De Montreal |
Screening assays based on mag and/or abhd6 for selecting insulin secretion promoting agents
|
|
US9290760B2
(en)
|
2010-09-15 |
2016-03-22 |
Alnylam Pharmaceuticals, Inc. |
Modified iRNA agents
|
|
JP5795072B2
(ja)
|
2010-10-22 |
2015-10-14 |
ソンギュングヮン ユニバーシティ ファウンデーション フォー コーポレート コラボレーション |
Ｒｎａ干渉を誘導する核酸分子及びその用途
|
|
US20130324591A1
(en)
|
2010-12-06 |
2013-12-05 |
Quark Pharmaceuticals, Inc. |
Double stranded oligonucleotide compounds comprising positional modifications
|
|
CN102719432B
(zh)
|
2011-03-29 |
2013-10-23 |
南京大学 |
特异性抑制肿瘤凋亡抑制基因Bcl2的双链不对称小核酸干扰分子asiRNA及其应用
|
|
KR101590586B1
(ko)
|
2011-05-30 |
2016-02-01 |
성균관대학교산학협력단 |
표적 유전자 발현 억제 및 면역 반응을 동시에 유발하는 이중가닥의 긴 간섭 ｒｎａ
|
|
JP5696991B2
(ja)
|
2011-10-28 |
2015-04-08 |
国立大学法人三重大学 |
ヒトＴＧＦβ１を発現するトランスジェニックマウス
|
|
JP6139671B2
(ja)
*
|
2012-05-22 |
2017-05-31 |
オリックス ファーマシューティカルズ インコーポレイテッドＯｌｉｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
細胞内貫通能を持ってｒｎａ干渉を誘導する核酸分子およびその用途
|
|
US9611473B2
(en)
|
2012-09-12 |
2017-04-04 |
Quark Pharmaceuticals, Inc. |
Double-stranded nucleic acid compounds
|
|
CN105683377B
(zh)
*
|
2013-07-05 |
2019-05-21 |
柏业公司 |
呼吸疾病相关基因特异性siRNA、含有siRNA的双螺旋寡RNA结构、含有它们的组合物用于预防或治疗呼吸疾病
|
|
EP3027223A1
(en)
|
2013-07-31 |
2016-06-08 |
QBI Enterprises Ltd. |
Methods of use of sphingolipid polyalkylamine oligonucleotide compounds
|
|
US9790506B2
(en)
|
2013-10-02 |
2017-10-17 |
The Regents Of The University Of California |
Diagnostic and screening methods for atopic dermatitis
|
|
US8980273B1
(en)
|
2014-07-15 |
2015-03-17 |
Kymab Limited |
Method of treating atopic dermatitis or asthma using antibody to IL4RA
|
|
KR102279110B1
(ko)
*
|
2014-04-30 |
2021-07-20 |
올릭스 주식회사 |
LasiRNA를 유효성분으로 포함하는 피부 미백용 조성물
|
|
US20170226507A1
(en)
|
2014-05-05 |
2017-08-10 |
The Brigham And Women's Hospital, Inc. |
Coordinate control of pathogenic signaling by the mir-130/301 family in pulmonary hypertension and fibroproliferative diseases
|
|
JP6892433B2
(ja)
|
2015-04-03 |
2021-06-23 |
ユニバーシティ・オブ・マサチューセッツＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｍａｓｓａｃｈｕｓｅｔｔｓ |
十分に安定化された非対称ｓｉｒｎａ
|
|
KR102772402B1
(ko)
|
2015-07-27 |
2025-02-26 |
올릭스 주식회사 |
멜라닌 생성을 억제하는 rna 복합체
|
|
JP7027311B2
(ja)
|
2015-11-16 |
2022-03-01 |
オリックス ファーマシューティカルズ，インコーポレーテッド |
ＭｙＤ８８又はＴＬＲ３を標的とするＲＮＡ複合体を使用した加齢黄斑変性の治療
|
|
EP3411480A4
(en)
|
2016-02-02 |
2020-01-22 |
Olix Pharmaceuticals, Inc. |
TREATMENT OF ATOPIC DERMATITIS AND ASTHMA USING RNA COMPLEXES THAT TARGET lL4R , TRPA1, OR F2RL1
|
|
KR102825945B1
(ko)
|
2016-02-02 |
2025-06-30 |
올릭스 주식회사 |
Angpt2 및 pdgfb를 표적화하는 rna 복합체를 사용하는 혈관신생 관련 질환의 치료
|
|
KR102339886B1
(ko)
|
2016-04-11 |
2021-12-17 |
올릭스 주식회사 |
연결 조직 성장 인자를 표적화하는 rna 복합체를 사용한 특발성 폐 섬유증의 치료 방법
|
|
KR101916652B1
(ko)
|
2016-06-29 |
2018-11-08 |
올릭스 주식회사 |
작은 간섭 rna의 rna 간섭효과 증진용 화합물 및 이의 용도
|
|
JP7424728B2
(ja)
|
2017-02-10 |
2024-01-30 |
オリック パルマセゥティカルズ インコーポレイテッド |
Ｒｎａ干渉のための長鎖の二本鎖ｒｎａ
|